| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8827565 | Transplantation Proceedings | 2017 | 10 Pages |
Abstract
Early bone marrow MSCs infusion on PODs 0, 3, and 7 are effective and safe for chronic renal allograft rejection in rats. MSCs hold significant promise for clinical transplantation to treat chronic renal allograft rejection and prolong the renal graft survival.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
P. Yu, Z. Wang, Y. Liu, Z. Xiao, Y. Guo, M. Li, M. Zhao,